National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 412933

History of Changes from the VAERS Wayback Machine

First Appeared on 1/4/2011

VAERS ID: 412933
Age:
Gender:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2010-12-15
Entered:2010-12-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Convulsion, Gait disturbance, Memory impairment, Mood altered, Movement disorder, Respiratory arrest, Tic, Cytogenetic analysis, Laboratory test, Abnormal behaviour, Metabolic function test, Brain injury

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1012USA01990

Write-up:Information has been received from a consumer who had received the information from the internet. The information in the internet was received by a consumer concerning her healthy daughter who was vaccinated with the first and second dose of GARDASIL shortly after the patient experienced seizures. The firstly seizure caused the patient to loss breath and she was hospitalized for 4 months. The patient experienced brain damage, memory deficiency, behavioral problems, extreme mood changes, walking disorder, tics and seizures. The patient had lost one year of school and would be able to return to school only when the medication would better control her seizures. The patient underwent 4 months of tests to detect metabolic disorders, genetic disorders and several rare conditions with no results yet. By the time of this report the outcome is unknown. The reporter felt that seizures, brain damage, memory deficiency, behavioral problems, extreme mood change, walking disorder and tics were related to therapy with GARDASIL. No further information is available.


Changed on 6/14/2014

VAERS ID: 412933 Before After
Age:
Gender:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2010-12-15
Entered:2010-12-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Convulsion, Gait disturbance, Memory impairment, Mood altered, Movement disorder, Respiratory arrest, Tic, Cytogenetic analysis, Laboratory test, Abnormal behaviour, Metabolic function test, Brain injury

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1012USA01990

Write-up:Information has been received from a consumer who had received the information from the internet. The information in the internet was received by a consumer concerning her healthy daughter who was vaccinated with the first and second dose of GARDASIL shortly after the patient experienced seizures. The firstly seizure caused the patient to loss breath and she was hospitalized for 4 months. The patient experienced brain damage, memory deficiency, behavioral problems, extreme mood changes, walking disorder, tics and seizures. The patient had lost one year of school and would be able to return to school only when the medication would better control her seizures. The patient underwent 4 months of tests to detect metabolic disorders, genetic disorders and several rare conditions with no results yet. By the time of this report the outcome is unknown. The reporter felt that seizures, brain damage, memory deficiency, behavioral problems, extreme mood change, walking disorder and tics were related to therapy with GARDASIL. No further information is available.


Changed on 4/14/2017

VAERS ID: 412933 Before After
Age:
Gender:Female
Location:Unknown
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2010-12-15
Entered:2010-12-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 1 UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Convulsion, Gait disturbance, Memory impairment, Mood altered, Movement disorder, Respiratory arrest, Tic, Cytogenetic analysis, Laboratory test, Abnormal behaviour, Metabolic function test, Brain injury

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC 'Split Type': WAES1012USA01990

Write-up:Information has been received from a consumer who had received the information from the internet. The information in the internet was received by a consumer concerning her healthy daughter who was vaccinated with the first and second dose of GARDASIL shortly after the patient experienced seizures. The firstly seizure caused the patient to loss breath and she was hospitalized for 4 months. The patient experienced brain damage, memory deficiency, behavioral problems, extreme mood changes, walking disorder, tics and seizures. The patient had lost one year of school and would be able to return to school only when the medication would better control her seizures. The patient underwent 4 months of tests to detect metabolic disorders, genetic disorders and several rare conditions with no results yet. By the time of this report the outcome is unknown. The reporter felt that seizures, brain damage, memory deficiency, behavioral problems, extreme mood change, walking disorder and tics were related to therapy with GARDASIL. No further information is available.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=412933&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166